JIN-A02
JIN-A02
Phase 2 small_molecule active
Quick answer
JIN-A02 for EGFR Mutant Advanced Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at INTENSITY THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTENSITY THERAPEUTICS, INC.
- Indication
- EGFR Mutant Advanced Non-small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active